What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q4 2022?

259 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock
Shares outstanding: 57,671,650
Total 13F shares: 55,885,167
Share change: +183,671
Total reported value: $1,993,935,462
Put/Call ratio: 0.81%
Reported price per share: $35.67
Number of holders: 259
Value change: +$8,207,715
Number of buys: 118
Number of sells: 104

Security key

868459108

Report period

Q4 2022

Institutions

259

Top holders

SUPN full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2023 Previous quarter: Q3 2022 SUPERNUS PHARMACEUTICALS, INC. SEC filings SUPERNUS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 868459108

Newer quarter: Q1 2023 Previous quarter: Q3 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

BlackRock Finance, Inc.

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2022

13F Lead comparable stake: 16% Showing first 8 of 50 holder rows. Open remaining rows

Rank 1 holder

BlackRock Finance, Inc.

13F

Ownership: 16%
Position: $311.98M

13F

Rank 2 holder

VANGUARD GROUP INC

13F

Ownership: 9.8%
Position: $192.28M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	16%	$311,983,000 9,216,574 shares	—	30 Sep 2022
VANGUARD GROUP INC	13F Company 13F	9.8%	$192,276,000 5,680,242 shares	—	30 Sep 2022
ARMISTICE CAPITAL, LLC	13F Company 13F	8%	$155,473,000 4,593,004 shares	—	30 Sep 2022
MACQUARIE GROUP LTD	13F Company 13F	4.1%	$80,247,000 2,370,120 shares	—	30 Sep 2022
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	3.9%	$76,854,000 2,270,480 shares	—	30 Sep 2022
STATE STREET CORP	13F Company 13F	3.3%	$65,104,000 1,923,295 shares	—	30 Sep 2022
GW&K Investment Management, LLC	13F Company 13F	3.1%	$59,830,000 1,767,489 shares	—	30 Sep 2022
Stephens Investment Management Group LLC	13F Company 13F	2.8%	$54,357,000 1,605,806 shares	—	30 Sep 2022

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
LOOMIS SAYLES & CO L P	13F Company 13F	2.8%	$54,204,000 1,601,303 shares	—	30 Sep 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	2.2%	$43,336,000 1,280,222 shares	—	30 Sep 2022
Aristotle Capital Boston, LLC	13F Company 13F	2%	$39,183,000 1,157,553 shares	—	30 Sep 2022
ASHFORD CAPITAL MANAGEMENT INC	13F Company 13F	1.9%	$37,047,000 1,094,443 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.6%	$32,120,000 948,910 shares	—	30 Sep 2022
Polar Capital Holdings Plc	13F Company 13F	1.4%	$26,881,000 794,120 shares	—	30 Sep 2022
Woodline Partners LP	13F Company 13F	1.4%	$26,869,000 793,767 shares	—	30 Sep 2022
AMERIPRISE FINANCIAL INC	13F Company 13F	1.4%	$26,861,000 793,557 shares	—	30 Sep 2022
VICTORY CAPITAL MANAGEMENT INC	13F Company 13F	1.3%	$26,317,000 777,469 shares	—	30 Sep 2022
FRONTIER CAPITAL MANAGEMENT CO LLC	13F Company 13F	1.2%	$23,790,000 702,808 shares	—	30 Sep 2022
NORTHERN TRUST CORP	13F Company 13F	1.2%	$23,377,000 690,583 shares	—	30 Sep 2022
RICE HALL JAMES & ASSOCIATES, LLC	13F Company 13F	1.2%	$22,995,000 679,311 shares	—	30 Sep 2022
Invesco Ltd.	13F Company 13F	1.1%	$21,476,000 634,428 shares	—	30 Sep 2022
Bank of New York Mellon Corp	13F Company 13F	0.9%	$17,643,000 521,227 shares	—	30 Sep 2022
MORGAN STANLEY	13F Company 13F	0.89%	$17,457,000 515,734 shares	—	30 Sep 2022
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	0.88%	$17,192,000 507,863 shares	—	30 Sep 2022
CONGRESS ASSET MANAGEMENT CO	13F Company 13F	0.88%	$17,178,000 507,463 shares	—	30 Sep 2022
Epoch Investment Partners, Inc.	13F Company 13F	0.85%	$16,628,000 491,240 shares	—	30 Sep 2022
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.81%	$15,834,000 467,774 shares	—	30 Sep 2022
NORGES BANK	13F Company 13F	0.74%	$14,507,196 428,573 shares	—	30 Sep 2022
Lisanti Capital Growth, LLC	13F Company 13F	0.66%	$12,971,000 383,180 shares	—	30 Sep 2022
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F Company 13F	0.65%	$12,690,000 374,901 shares	—	30 Sep 2022
Nuveen Asset Management, LLC	13F Company 13F	0.65%	$12,643,000 373,509 shares	—	30 Sep 2022
Tributary Capital Management, LLC	13F Company 13F	0.62%	$12,018,000 355,024 shares	—	30 Sep 2022
PRINCIPAL FINANCIAL GROUP INC	13F Company 13F	0.59%	$11,606,000 342,860 shares	—	30 Sep 2022
BANK OF AMERICA CORP /DE/	13F Company 13F	0.58%	$11,343,000 335,085 shares	—	30 Sep 2022
Mesirow Institutional Investment Management, Inc.	13F Company 13F	0.56%	$11,004,000 325,085 shares	—	30 Sep 2022
EMERALD ADVISERS, LLC	13F Company 13F	0.54%	$10,611,000 313,477 shares	—	30 Sep 2022
SCOUT INVESTMENTS, INC.	13F Company 13F	0.54%	$10,582,000 312,617 shares	—	30 Sep 2022
CITADEL ADVISORS LLC	13F Company 13F	0.54%	$10,483,000 309,691 shares	—	30 Sep 2022
S&T BANK/PA	13F Company 13F	0.52%	$10,197,000 301,226 shares	—	30 Sep 2022
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F Company 13F	0.52%	$10,070,000 297,500 shares	—	30 Sep 2022
EMERALD MUTUAL FUND ADVISERS TRUST	13F Company 13F	0.47%	$9,260,000 273,568 shares	—	30 Sep 2022
SEI INVESTMENTS CO	13F Company 13F	0.42%	$8,277,000 244,521 shares	—	30 Sep 2022
GOLDMAN SACHS GROUP INC	13F Company 13F	0.38%	$7,506,000 221,732 shares	—	30 Sep 2022
JPMORGAN CHASE & CO	13F Company 13F	0.36%	$7,123,000 210,406 shares	—	30 Sep 2022
NEW YORK STATE COMMON RETIREMENT FUND	13F Company 13F	0.34%	$6,619,000 195,553 shares	—	30 Sep 2022
Legal & General Group Plc	13F Company 13F	0.32%	$6,207,000 183,367 shares	—	30 Sep 2022
PICTET ASSET MANAGEMENT SA	13F Company 13F	0.28%	$5,546,000 163,848 shares	—	30 Sep 2022
RHUMBLINE ADVISERS	13F Company 13F	0.28%	$5,460,000 161,304 shares	—	30 Sep 2022
CW Advisors, LLC	13F Company 13F	0.24%	$4,657,000 137,596 shares	—	30 Sep 2022
Phocas Financial Corp.	13F Company 13F	0.23%	$4,488,000 132,598 shares	—	30 Sep 2022

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

259

55,885,167

Rows loaded

261

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

236

Q4 2022 holders

259

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

Q4 2022 13F Holders as of 31 Dec 2022

Holder history for CUSIP 868459108

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

BlackRock Finance, Inc.

VANGUARD GROUP INC

ARMISTICE CAPITAL, LLC

Institutional holders as of Q4 2022

Compare Q4 2022 vs Q3 2022 Across Filers